Michael A. Eller
About Michael A. Eller
Michael A. Eller serves as the Chief of the Vaccine Translational Research Branch at the National Institutes of Health, a position he has held since 2020.
Work at National Institutes of Health
Michael A. Eller serves as the Chief of the Vaccine Translational Research Branch within the Vaccine Research Program (VRP) at the Division of AIDS (DAIDS) under the National Institute of Allergy and Infectious Diseases (NIAID). He has held this position since 2020, contributing to the advancement of vaccine research and development. His role involves overseeing research initiatives aimed at improving vaccine efficacy and safety, particularly in the context of infectious diseases.
Background
Michael A. Eller is based in Rockville, Maryland, United States. His professional focus is on vaccine translational research, which bridges the gap between laboratory research and clinical application. This role is critical in the development of vaccines that can effectively combat various infectious diseases.
Education and Expertise
While specific educational details are not provided, Michael A. Eller's position as Chief of the Vaccine Translational Research Branch indicates a strong background in immunology, vaccine development, and translational research methodologies. His expertise is essential for leading research teams and guiding projects that aim to translate scientific discoveries into viable vaccine candidates.
Achievements
Since joining the National Institutes of Health in 2020, Michael A. Eller has been involved in significant research initiatives within the Vaccine Translational Research Branch. His leadership contributes to the ongoing efforts to develop effective vaccines, although specific achievements or projects are not detailed in the provided information.